Background illustration for clinical trials search

Sarcoma Clinical Trials

Browse 918 sarcoma clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.

Filter
1

GI-102 Alone or With Pembrolizumab Before Surgery for Treatment of Recurrent or Progressive IDH Wildtype Glioblastoma and IDH Mutated Grade 4 Astrocytoma

for
Glioblastoma, IDH-Wildtype,
Location: Rochester MN
Sponsor: Mayo Clinic

Sex: All

Age: 18+

Code: NCT07301268

Phase2, Recruiting

A Phase I Trial Anti-CC Chemokine Receptor 4 Chimeric Antigen Receptor T Cells (CCR4 CAR T Cells) for CCR4 Expressing T-cell Malignancies Including Peripheral T-cell Non-Hodgkin Lymphoma (PTCL) and Cutaneous T-cell Non-Hodgkin Lymphoma (CTCL)

for
Relapsed and/or Refractory Mature T Cell Malignancy,
Location: Bethesda MD
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18 - 70+

Code: NCT07055477

Phase1, Recruiting

Phase 1/2a Study to Assess the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of WEF-001 as Monotherapy in Advanced KRAS-Mutant Solid Tumours.

for
Advanced or Metastatic KRAS-mutant Tumor in Pancreatic Adenocarcinoma,
Location: Toronto, Dallas TX, San Antonio TX
Sponsor: Auricula Biosciences Inc.

Sex: All

Age: 18+

Code: NCT07148128

Phase1, Phase2, Recruiting

Epcoritamab Plus Standard of Care Platinum-Based Chemotherapy and Autologous Hematopoietic Cell Transplant for the Treatment of Relapsed or Refractory Large B-cell Lymphoma

for
Recurrent Diffuse Large B-Cell Lymphoma,
Location: Sacramento CA
Sponsor: University of California, Davis

Sex: All

Age: 18+

Code: NCT06905509

Phase2, Recruiting

Loncastuximab Tesirine and Rituximab as Bridging Therapy Before Standard-of-care CAR-T Therapy in Patients With Large B-cell Lymphoma (CORAL)

for
Relapsed or Refractory Large B-cell Lymphoma
Location: Salt Lake City UT
Sponsor: University of Utah

Sex: All

Age: 18+

Code: NCT06788964

Phase2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Phase 2 Study of WU-CART-007, an Anti-CD7 Allogeneic CAR-T Cell Therapy in T-Cell Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma (T-RRex)

for
T-cell Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma
Location: New York NY, Philadelphia PA, Norfolk VA,
Sponsor: Allotera Therapeutics

Sex: All

Age: 0+

Code: NCT06514794

Phase2, Recruiting

A Study to Compare the Efficacy and Safety of Golcadomide in Combination With Rituximab (Golca + R) vs Investigator's Choice in Participants With Relapsed/Refractory Follicular Lymphoma Who Have Received at Least 1 Prior Line of Systemic Therapy (GOLSEEK-4)

for
Follicular Lymphoma
Location: Towson MD, Fredericksburg VA, Roanoke VA, Toronto,
Sponsor: Celgene

Sex: All

Age: 18+

Code: NCT06911502

Phase3, Recruiting

Ropeginterferon in Patients w/Cutaneous T-Cell Lymphoma (CTCL)

for
Cutaneous T Cell Lymphoma
Location: Tampa FL
Sponsor: H. Lee Moffitt Cancer Center and Research Institute

Sex: All

Age: 18+

Code: NCT07047885

Phase1, Recruiting

Zanubrutinib in Combination With Sonrotoclax for the Treatment of Underrepresented Ethnic and Racial Minorities With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma

for
Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma,
Location: Duarte CA
Sponsor: City of Hope Medical Center

Sex: All

Age: 18+

Code: NCT06859008

Phase1, Recruiting

HM2023-43:Ph 2 Trial of Tafasitamab With Lenalidomide+Rituximab in Treatment-naive FL and MZL

for
Follicular Lymphoma, Marginal Zone Lymphoma
Location: Minneapolis MN
Sponsor: Masonic Cancer Center, University of Minnesota

Sex: All

Age: 18+

Code: NCT06792825

Phase2, Recruiting

A Study of Pirtobrutinib (LOXO-305) Versus Ibrutinib in Participants With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)

for
Chronic Lymphocytic Leukemia, Leukemia, Lymphocytic,
Location: Quebec, Bethesda MD, Richmond VA, West Palm Beach FL,
Sponsor: Loxo Oncology, Inc.

Sex: All

Age: 18+

Code: NCT05254743

Phase3, Recruiting

A Study of Reduced Dose Radiation Therapy for People With B-Cell Lymphomas

for
Follicular Lymphoma, Marginal Zone Lymphoma
Location: Commack NY, Uniondale NY, Harrison NY, New York NY,
Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All

Age: 18+

Code: NCT07029217

Phase3, Recruiting

BrECADD Therapy in Stage 2 B-IV Hodgkin Lymphoma

for
Hodgkin Lymphoma, Advanced Hodgkin Lymphoma
Location: Miami FL
Sponsor: University of Miami

Sex: All

Age: 18 - 60

Code: NCT07002216

Phase2, Recruiting

TLN-121 in Relapsed or Refractory Non-Hodgkin Lymphomas

for
Lymphoma, Lymphoma, Non Hodgkin
Location: New York NY, Philadelphia PA, Grand Rapids MI,
Sponsor: Treeline Biosciences, Inc.

Sex: All

Age: 18+

Code: NCT07082803

Phase1, Recruiting

A Study of Alectinib and Duvelisib in People With Anaplastic Lymphoma Kinase-Positive Anaplastic Large Cell Lymphoma (ALK+ALCL)

for
Anaplastic Lymphoma Kinase, Anaplastic Large Cell Lymphoma
Location: Commack NY, Uniondale NY, Harrison NY, New York NY,
Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All

Age: 18+

Code: NCT07001384

Phase1, Recruiting

Evaluating the Effects of Hemoglobin Threshold-specific Packed Red Blood Cell Transfusions on Quality of Life and Functional Outcomes in Patients With High-grade Myeloid Neoplasms, Acute Myeloid Leukemia, or B Acute Lymphoblastic Lymphoma/Leukemia

for
Acute Myeloid Leukemia, B Acute Lymphoblastic Leukemia,
Location: Seattle WA
Sponsor: University of Washington

Sex: All

Age: 18+

Code: NCT06710418

Recruiting

A Study of Daratumumab and Dose-Adjusted EPOCH in Plasmablastic Lymphoma

for
Plasmablastic Lymphoma,
Location: New York NY, Philadelphia PA, Baltimore MD,
Sponsor: AIDS Malignancy Consortium

Sex: All

Age: 18+

Code: NCT04139304

Early_phase1, Recruiting

A Study of (LY3527727) Pirtobrutinib in Participants With Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma or Non-Hodgkin Lymphoma

for
Chronic Lymphocytic Leukemia, Non-Hodgkin Lymphoma
Location: Boston MA, Lake Success NY, New York NY,
Sponsor: Eli Lilly and Company

Sex: All

Age: 18+

Code: NCT06876662

Recruiting

Combating Cancer-Related Fatigue: A Personalized Supportive Care Program

for
Indolent Lymphomas, Lymphoma, Chronic Lymphocytic Leukemia,
Location: Chapel Hill NC
Sponsor: UNC Lineberger Comprehensive Cancer Center

Sex: All

Age: 18+

Code: NCT06860880

Recruiting

A Study to Investigate Progression-Free Survival With Sonrotoclax Plus Obinutuzumab Or Sonrotoclax Plus Rituximab Compared With Venetoclax Plus Rituximab Treatment In Patients With Relapsed and/or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CELESTIAL-RRCLL)

for
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Location: St. John's, Boston MA, Norwich CT, New Haven CT, Quebec,
Sponsor: BeOne Medicines

Sex: All

Age: 18+

Code: NCT06943872

Phase3, Recruiting